ArticleHeliyon2023
Endocarditis induced by
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 3 citations in OpenAlex.
- Characterization of FosA13, a novel fosfomycin glutathione transferase identified in aFrontiers in cellular and infection microbiology · 2025Article
- Distribution diversity and expression regulation of class 1 integron promoters in clinical isolates ofFrontiers in microbiology · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The gram-positive cocci is the most common pathogens of infective endocarditis (IE), and it is rarely induced by gram negative bacteria. Only one prior case has been described, in which a patient reported with IE caused by Case summary: We describe a case of 34-year-old patient presented to the hospital with recurrent fever and pneumonia since 5 months. He was diagnosed with infective endocarditis with tricuspid vegetation by transthoracic echocardiography (TTE). Two blood culture tests demonstrated the growth of Conclusion: This was a unique case of IE induced by an extremely rare agent in an immunocompetent patient without underlying valvular abnormalities. Broad-antibiotics with β-lactam enzyme inhibition should be used on time for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.